The Tower Healthcare Platform

"We are on the verge of a new era in healthcare.
The healthcare sector today is what the technology sector was 20 years ago."


Jerry Lee

Managing Director
Goldman Sachs Global Healthcare Group
January 2024


THE
TOWER HEALTHCARE
PLATFORM

The Tower Healthcare Platform is a multi-manager platform of top-tier L/S healthcare managers that was designed to address eight concerns facing most investors:

To provide investors with a way to capitalize on the extraordinary opportunities in the healthcare sector, Tower Capital offers investors the option to invest with one or more top-tier L/S healthcare managers, each of which has generated exceptional risk-adjusted returns.

Objectives


I. Returns

Many investors seek alternative investments that have the prospect of generating attractive returns.

The massive transformation taking place in the healthcare sector will provide the L/S healthcare managers on the Tower Healthcare Platform the potential to produce attractive returns.

  • "Innovation in healthcare is a megatrend that will yield new investment opportunities for investors."
    Morgan Stanley Wealth Management
    March 10, 2023
  • "Healthcare is increasingly important with tremendous investment opportunities. It is time for investors to take a closer look at it."
    Ben Bei, BlackRock
    September 2023
  • "Healthcare, a $5 trillion market in the U.S. (18% of GDP), is undergoing a Cambrian explosion."
    Paris Heymann, Index Ventures
    March 2024
  • "The global healthcare sector is undergoing a period of unprecedented transformation."
    Briana Contreras, Accenture
    January 21, 2023
  • "Healthcare is well positioned to be the megatrend of the 2020s."
    Mark Denham, FI News First
    April 16, 2024

The Tower Healthcare Platform is a multi-manager platform that provides investors the option to invest with one or more L/S healthcare managers.


II. TAXES

Because many investors are concerned about an increase in taxes, the Tower Healthcare Platform offers investors the ability to invest with the L/S healthcare managers through an Insurance Dedicated Fund (“IDF”).

The IDF allows investors to defer or eliminate all taxes on all the gains generated by the managers.

  • "IDFs offer UHNW investors a way to participate in hedge funds and other alternative investments without incurring a current tax liability each year."
    Morgan Stanley Wealth Management
    2023
  • "An IDF remains a mostly under-recognized tool in wealth management, yet it represents the hidden jewel in wealth management."
    Signature FD
    Atlantic Business Chronicle, 2023

And, because of the tax structure, the IDF does not generate an annual K-1.

If the L/S healthcare managers generate a positive performance, the tax-free compounding will have a significant impact on the investor's net return.


III. FEES

Most investors are concerned about high hedge fund fees.

Rather than being paid the typical Annual Performance Fee, the L/S healthcare managers are deferring their entire Performance Fees until one of 3 triggers:

  • the investor redeems from the fund;
  • the PM is replaced as the PM of the fund;
  • the 10-year anniversary of the investor's investment in the fund.

The advantages of the Deferred Performance Fee are powerful:

  • The Deferred Performance Fee ensures that the investor will pay a Performance Fee only if the manager has generated a positive performance at the time the investor redeems from the fund.
  • The Deferred Performance Fee provides investors with the opportunity to have their investment compound without paying an Annual Performance Fee. If the manager generates a positive performance, the compounding of the Performance Fee-Free returns will have a meaningful impact on the investor's total return.
  • The Deferred Performance Fee also protects investors from the "Performance Fee Trap" that exists with virtually every hedge fund manager. With an Annual Performance Fee, investors pay a Performance Fee every year the manager generates a positive performance. But if the manager generates a net loss at the time the investor redeems, the investor is caught in the "Performance Fee Trap" of not being able to recoup a previously paid Performance Fee.

IV. PHILANTHROPY

While generating attractive returns is the 1st priority of the Tower Healthcare Platform, philanthropy is the 2nd priority. Many investors who invest with the L/S healthcare managers on the Tower Healthcare Platform are committed to philanthropy. For those investors, the IDF tax structure provides the most powerful and flexible charitable giving structure available.

While most investors use DAFs, CLATs, CRATs, GRATs, trusts, and private foundations, each of these structures requires the investor to relinquish control over their assets.

The IDF allows investors to retain complete control over their assets until the investor decides to make a charitable contribution.

In addition, because the IDF provides investors with a deferral of all taxes and a deferral of all Performance Fees, if the L/S healthcare managers generate positive returns, the size of the charitable gift will be significantly larger compared to a charitable gift from an investment with annual taxes and annual Performance Fees.

The IDF also has the potential to provide investors a significantly higher tax deduction.

Philanthropy personifies Tower Capital's "North Star". Given the firm's commitment to philanthropy and healthcare, Tower Capital is contributing 5% of the firm's revenues to the Sloan Kettering Institute, which is the research arm of Memorial Sloan Kettering.


V. LIQUIDITY

Most alternative funds have onerous liquidity terms, which is a concern for most investors.

While lock-ups and illiquidity are advantageous for managers, they are disadvantageous for investors.

Given that the L/S healthcare managers are investing exclusively in publicly-traded securities, Tower Capital believes investors should not be subject to onerous liquidity terms.

To address this issue, the L/S healthcare managers provide investors quarterly liquidity with no lock-up.


VI. CONFLICT OF INTERESTS

Most banks and investment firms emphasize that their clients' interests "come first". But very few firms deliver this.

As the L/S healthcare managers are deferring their performance fees until the investor redeems, this ensures that the interests of the investors do indeed "come first".

This Deferred Performance Fee is a true alignment of interests between the investors and the managers – something quite rare on Wall St.

And, as the L/S healthcare managers are offering quarterly liquidity with no lock-ups, this further ensures that the interests of the investors "come first".


VII. PAST VS. FUTURE PERFORMANCE

Most investors make investment decisions based on a manager's past performance rather than on what has driven this performance. A critical component of Tower Capital's manager due diligence is to understand the manager's edge and determine whether this edge has the potential to be sustainable going forward.

In addition, Tower Capital believes it is critical to understand the future macro environment for a manager's strategy as this will provide either a tailwind or a headwind for the manager.

There are four dynamics taking place in the healthcare sector which Tower Capital believes will provide L/S healthcare managers a significant tailwind:

  • The aging global population guarantees that the healthcare sector will be a growth sector.
  • AI, Quantum Mechanics, and biotech are completely transforming the healthcare sector. This transformation will provide L/S healthcare managers enormous opportunities to capitalize on what inevitably will be enormous dislocations in company valuations.
  • Healthcare companies do not trade based upon EBITA but rather as M&A opportunities. Therefore, healthcare stocks typically have a lower beta compared to the overall equity markets which can provide diversification for high beta portfolios.
  • Healthcare is viewed as a defensive sector which can also provide an important diversification for an investor's portfolio.

Although there can be no guarantee that a L/S healthcare manager will generate similar returns to their historic returns, these four dynamics will provide L/S healthcare managers a significant tailwind.


VIII. IMPACT INVESTING

Many investors would like to make allocations to Impact Investments, but the low returns of most Impact Investments are a significant impediment.

By investing in the healthcare sector, investors will have the ultimate impact on society: helping people live longer and healthier lives.

  • "If you zoom out into the future and you look back and ask the question, 'What was Apple's greatest contribution to mankind?' it will be about health."
    Tim Cook, Apple CEO
    May 3, 2022

And, if an investor eventually decides to earmark their investment with a L/S healthcare manager to a charitable institution, this will provide a double impact.

Tower Capital

Value Add

Tower Capital provides investors with the opportunity to capitalize on the growth opportunities in the healthcare sector by investing with one or more top-tier L/S healthcare managers.

Tower Capital is an independent advisor. The investor's decision to invest with one or more L/S healthcare managers is left entirely up to the investor.

Tower Capital has been able to secure valuable capacity with top-tier L/S healthcare managers for three reasons:

  • Investors will invest with the managers through a tax structure that lends itself to a longer-term time horizon;
  • Investors understand that the healthcare sector is volatile but because they have a longer-term time horizon, short-term volatility is not an important consideration;
  • The investors understand that the tax-free compounding of Deferred Performance Fee has the potential to generate significant wealth.

The healthcare sector is a volatile sector with many risks not found in other sectors. These risks pose a significant deterrent for many investors investing in the healthcare sector. By providing investors the opportunity to invest in the sector through top-tier L/S healthcare managers, investors will be able to capitalize on the managers' proven track records of generating attractive returns as well as managing the risks inherent in the healthcare sector.

Since its founding in 1992, Tower Capital has invested over $3.0 billion in over 50 L/S managers.

The
Healthcare
Sector

an immense investment opportunity
01

Aging Population

The aging global population will provide an enormous growth engine for the healthcare sector. In 2024, 10% of the world's population was over 65. By 2050 16% will be over 65. The aging global population will guarantee significant growth in the healthcare sector.

02

U.S. SPENDING

U.S. healthcare spending is expected to increase from $4.8 trillion in 2023 to $7.7 trillion in 2033, a 60% increase over just 10 years. And, by 2033, healthcare spending will account for one-fifth of the U.S. economy. Increased healthcare spending will guarantee significant growth in the sector.

03

GLOBAL SPENDING

In 2023, U.S. healthcare spending was $4.9 trillion. It is projected to be $7.7 trillion in 2032. In 2022, global healthcare spending was $10.2 trillion, and it is projected to be $16 trillion in 2032. Global healthcare spending will provide a significant growth engine for the healthcare sector for many years to come.

04

FDA

The FDA approved 55 new drugs in 2023 which is almost 50% more than in 2022 putting it back on track with historical levels. The FDA will continue its Fast Track Program to facilitate and expedite the review of new drugs to treat serious and unmet medical needs.

05

Technology

The integration of AI, Big Data, and Quantum Computing is revolutionizing the healthcare sector. Global spending on AI is expected to grow at a staggering 42% per year for the next 10 years from $19.3 billion in 2023 to $613.8 billion in 2034.

06

Biopharma

By 2040, groundbreaking hyper-tailored biopharma therapies will be developed to cure or prevent diseases rather than treat symptoms. Looking back in 2040, our current approach to disease and treatments will be considered crude.

07

Genomics

The first human genome was completed in 2003 at a cost of $3 billion. In 2024, the cost of a human genome was approximately $600. Genome sequencing represents a paradigm shift that will revolutionize the healthcare sector.

08

R&D

In 2023, the healthcare sector spent more on R&D than any other S&P sector, for the first time ever. This will result in huge investment opportunities in the healthcare sector.

Tower Capital

History
2020 - 2025

HEALTHCARE SECTOR

Since 2020, Tower Capital has specialized in the healthcare sector having analyzed over 80 L/S healthcare managers and invested in 7 L/S healthcare managers on behalf of several Single Famity Offices.

2005

HYPOVEREINSBANK

Transaction

In 2005, Mr. Doyle sold the track records and the $2.3 billion in AUM of Tower Capital's 13 L/S equity FoFs to HypoVereinsbank, at the time, the 2nd largest German bank.

2000

$ 2.3 BILLION
Under Management

Between 1992-2005, Tower Capital specialized in structuring L/S equity FoFs for institutional investors. Over this time, the firm invested over $3 billion in over 50 L/S equity managers. In 2005, with AUM of $2.3 billion, Tower Capital was one of the five largest FoFs in the hedge fund industry.

1992

TOWER CAPITAL, INC.

Establishment

Tower Capital was founded with a $1 million investment in a single U.S. L/S equity manager. The seed capital for this investment came from Banca del Gottardo, Lugano.